Literature DB >> 16634364

Immunodeficiency in the lupus clinic.

M Y Karim1.   

Abstract

Systemic lupus erythematous (SLE) and immunodeficiency are linked in various ways. For example, rare genetic complement deficiencies can pre-dispose to developing SLE, whilst some treatments for SLE can cause secondary immunodeficiencies. Various case reports describe SLE patients who have concomitant or later develop antibody deficiency, possibly related to immunosuppressive treatment, or possibly related to the lupus itself. Other components of the immune system, innate and adaptive may also be affected. Immunosuppressive treatment may also cause infections in the absence of defects on routine immunological testing. It is important for the clinician to be aware of the associations between SLE and immunodeficiency to ensure optimal investigation and management. This review focuses on aspects of humoral and cellular immunity, and their association with SLE.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16634364     DOI: 10.1191/0961203306lu2282rr

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  1 in total

1.  Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Authors:  Agnieszka Klonowska-Szymczyk; Anna Wolska; Tadeusz Robak; Barbara Cebula-Obrzut; Piotr Smolewski; Ewa Robak
Journal:  Mediators Inflamm       Date:  2014-02-25       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.